Adiponectin
| Alternate Names | Total Adiponectin, ADP |
| Intended Use | Used for the quantitative determination of total adiponectin. |
| Clinical Significance | Adiponectin (ADP) is one of the major proteins secreted by adipose tissue and has been found to function as an anti-atherogenic molecule. ADP may be useful to assess those at risk of metabolic syndrome or diabetes due to poor lifestyle choices as lower adiponectin levels are associated with increased risk. |
| Specimen | Lithium Heparin Plasma (Preferred), Serum (Acceptable) |
| Container Type | Green Top Tube (Preferred), Red/Yellow Top Tube (Acceptable)
|
| Methodology | Immunoturbidimetric |
| Reference Range | Female: >13.0 ug/mL Male: >10.0 ug/mL |
| Stability | Refrigerated: 7 days |
| Transport Temp | Refrigerate 2°-8° C |
| Instructions | None |
| Days Performed | Daily |
| Report Available | 1-2 days |
| NY State Available | No |
| Assay Category | Laboratory Developed Test: This test was developed and its performance characteristics determined by Eurofins Ascend Clinical in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration. |
| LOINC Code | 47828-9 |
| CPT Code | 83520 |
OR 